{"altmetric_id":4686992,"selected_quotes":["Now that $NVS has changed dates for the ADACCESS study, could $NVS be behind this filing?","@biosimilarz For the purists among us; here's the CT entry for the study; Wot no Phase I study info\/data?"],"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["Sandoz"],"first_seen_on":"2015-10-28T12:16:59+00:00","issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1473083466,"links":["http:\/\/clinicaltrials.gov\/ct2\/show\/NCT02016105?term=psoriasis&rcv_d=14&show_rss=Y","https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02016105?term=ADACCESS&rank=1","http:\/\/clinicaltrials.gov\/ct2\/show\/NCT02016105","https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02016105"],"nct_id":"NCT02016105","pubdate":"2013-12-14T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira (ADACCESS)","type":"clinical_trial_study_record"},"altmetric_score":{"score":2,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":2},"context_for_score":{"all":{"total_number_of_other_articles":8331095,"mean":7.02255168024,"rank":3613315,"this_scored_higher_than_pct":55,"this_scored_higher_than":4598746,"rank_type":"exact","sample_size":8331095,"percentile":55},"similar_age_3m":{"total_number_of_other_articles":245305,"mean":9.7879451619215,"rank":91957,"this_scored_higher_than_pct":60,"this_scored_higher_than":148728,"rank_type":"exact","sample_size":245305,"percentile":60},"this_journal":{"total_number_of_other_articles":24330,"mean":10.460080808911,"rank":9640,"this_scored_higher_than_pct":59,"this_scored_higher_than":14387,"rank_type":"exact","sample_size":24330,"percentile":59},"similar_age_this_journal_3m":{"total_number_of_other_articles":1115,"mean":14.525154398564,"rank":454,"this_scored_higher_than_pct":58,"this_scored_higher_than":650,"rank_type":"exact","sample_size":1115,"percentile":58}}},"demographics":{"poster_types":{"member_of_the_public":2,"researcher":1},"users":{"twitter":{"cohorts":{"Members of the public":2,"Scientists":1}}},"geo":{"twitter":{"GB":1}}},"counts":{"total":{"posts_count":7},"twitter":{"unique_users_count":3,"unique_users":["biosimilarz","AndyBiotech","j_jay_z"],"posts_count":4},"facebook":{"unique_users_count":2,"unique_users":["444542355641199","100004389341043"],"posts_count":3}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/biosimilarz\/status\/413992536584101889","license":"public","citation_ids":[4686992],"posted_on":"2013-12-20T11:21:26+00:00","author":{"name":"Biosimilarz","url":"http:\/\/www.biosimilarz.com","image":"https:\/\/pbs.twimg.com\/profile_images\/798450758924505088\/diz4XN6t_normal.jpg","description":"Musings on all things #biosimilar with some personal stuff thrown in. All words are my own!","id_on_source":"biosimilarz","tweeter_id":"239982538","geo":{"lt":51.19242,"ln":0.27532,"country":"GB"},"followers":1809},"tweet_id":"413992536584101889"},{"url":"http:\/\/twitter.com\/AndyBiotech\/status\/414544621289492480","license":"public","citation_ids":[4686992],"posted_on":"2013-12-21T23:55:14+00:00","author":{"name":"Andy Biotech","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000074240482\/d961ebeb9f4fe6b084a68663b9a36738_normal.png","description":"#Biotech Investor | Recovering Scientist | May have positions in mentioned names | Opinions are strictly my own and not intended as investment advice","id_on_source":"AndyBiotech","tweeter_id":"632341632","geo":{"lt":null,"ln":null},"followers":31525},"tweet_id":"414544621289492480"},{"url":"http:\/\/twitter.com\/j_jay_z\/status\/414758562276315136","license":"public","rt":["AndyBiotech"],"citation_ids":[4686992],"posted_on":"2013-12-22T14:05:21+00:00","author":{"name":"joyz","image":"https:\/\/pbs.twimg.com\/profile_images\/512086208214605825\/yL1wweGf_normal.jpeg","id_on_source":"j_jay_z","tweeter_id":"229862784","geo":{"lt":null,"ln":null},"followers":90},"tweet_id":"414758562276315136"},{"url":"http:\/\/twitter.com\/biosimilarz\/statuses\/772794187142066176","license":"gnip","citation_ids":[4686992],"posted_on":"2016-09-05T13:51:06+00:00","author":{"name":"Biosimilarz","url":"http:\/\/www.biosimilarz.com","image":"https:\/\/pbs.twimg.com\/profile_images\/798450758924505088\/diz4XN6t_normal.jpg","description":"Musings on all things #biosimilar with some personal stuff thrown in. All words are my own!","id_on_source":"biosimilarz","tweeter_id":"239982538","geo":{"lt":51.19242,"ln":0.27532,"country":"GB"},"followers":1809},"tweet_id":"772794187142066176"}],"facebook":[{"title":"Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and","url":"https:\/\/www.facebook.com\/444542355641199\/posts\/541754439253323","license":"public","citation_ids":[4686992],"posted_on":"2013-12-20T01:45:32+00:00","summary":"#Psoriasis News Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira\n\nCondition: Chronic Plaque Psoriasis\nInterventions: Drug: GP2017 Adalimumab; Drug: Humira \u00ae Adalimumab\nSponsor: \u2026","author":{"name":"Psoriasis News","url":"https:\/\/www.facebook.com\/444542355641199","facebook_wall_name":"Psoriasis News","image":"https:\/\/graph.facebook.com\/444542355641199\/picture","id_on_source":"444542355641199"}},{"title":"Mobile Uploads","url":"https:\/\/www.facebook.com\/100004389341043\/posts\/797977486943309","license":"public","citation_ids":[4686992],"posted_on":"2015-02-01T07:53:26+00:00","summary":"Have you been diagnosed with plaque-type psoriasis, but still experience symptoms despite treatment?\n\nPlaque Psoriasis \nParticipating in a new clinical research study of a biologic treatment may be the right approach for you!\n\nAn investigational medication","author":{"name":"AshwiNi Kolhar","url":"https:\/\/www.facebook.com\/100004389341043","facebook_wall_name":false,"image":"https:\/\/graph.facebook.com\/100004389341043\/picture","id_on_source":"100004389341043"}},{"title":"Mobile Uploads","url":"https:\/\/www.facebook.com\/100004389341043\/posts\/1009254162436382","license":"public","citation_ids":[4686992],"posted_on":"2015-02-01T07:53:02+00:00","summary":"Have you been diagnosed with plaque-type psoriasis, but still experience symptoms despite treatment?\n\nPlaque Psoriasis \nParticipating in a new clinical research study of a biologic treatment may be the right approach for you!\n\nAn investigational medication","author":{"name":"AshwiNi Kolhar","url":"https:\/\/www.facebook.com\/100004389341043","facebook_wall_name":false,"image":"https:\/\/graph.facebook.com\/100004389341043\/picture","id_on_source":"100004389341043"}}]}}